Oppenheimer raised the firm’s price target on Hamilton Lane (HLNE) to $220 from $190 and keeps an Outperform rating on the shares. The firm adjusted targets in the alternative asset manager group as part of a Q4 preview.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLNE:
